Heart Failure Clinical Trials

Find Heart Failure Clinical Trials Near You

Acute Dyspnea in the Emergency Department: Diagnostic Evaluation of Inferior Vena Cava Ultrasound Integrated With Multimodal Point-of-Care Ultrasound and Clinical Data

Status: Recruiting
Location: See location...
Study Type: Observational
SUMMARY

Acute dyspnea is a common reason for emergency department (ED) admission and is frequently caused by acute heart failure with pulmonary edema. Rapid differentiation between cardiogenic and non-cardiogenic causes of dyspnea is essential to guide early treatment and risk stratification. However, no single gold standard exists for the assessment of venous congestion in the acute setting. This prospective observational study aims to evaluate the diagnostic accuracy of respiratory variation in inferior vena cava (IVC) diameter measured by point-of-care ultrasound (POCUS) in identifying acute pulmonary edema in patients presenting to the ED with acute respiratory failure. In addition, the study investigates whether integration of IVC ultrasound with lung ultrasound, bedside cardiac ultrasound, and selected clinical and laboratory variables - such as hemoglobin and plasma protein changes - improves diagnostic performance and prognostic stratification.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• Adults aged ≥18 years.

• Presentation to the emergency department with acute dyspnea and acute respiratory failure, defined by at least one of the following:

‣ PaO₂ \< 60 mmHg on room air, or

⁃ Oxygen saturation (SpO₂) \< 90% on room air, or

⁃ PaO₂/FiO₂ ratio \< 300.

• Ability to provide written informed consent or eligibility for deferred consent according to local regulations.

• Undergoing standard diagnostic evaluation including laboratory tests and chest imaging as part of routine clinical care.

Locations
Other Locations
Italy
Azienda Ospedaliero-Universitaria Maggiore della Carità
RECRUITING
Novara
Contact Information
Primary
Francesco Gavelli, MD, PhD
francesco.gavelli@uniupo.it
+3903213733097
Time Frame
Start Date: 2025-11-01
Estimated Completion Date: 2028-11
Participants
Target number of participants: 200
Related Therapeutic Areas
Sponsors
Leads: Università degli Studi del Piemonte Orientale Amedeo Avogadro

This content was sourced from clinicaltrials.gov